NCT02873169

Determination of Risk Factors of Ventricular Arrhythmias (VAs) After Implantation of Continuous Flow Left Ventricular Assist Device With Continuous Flow Left Ventricular Assist Device (CF-LVAD)

Interest of Implantable Cardioverter-defibrillator in Primary Prevention in Patient With Continuous Flow Left Ventricular Assist Device (CF-LVAD)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 681 (actual)
• Sponsor: Rennes University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Determination of risk factors of ventricular arrhythmias (VAs) after implantation of continuous flow left ventricular assist device in order to characterize which patient requires ICD implantation in primary prevention.

Conditions

• Severe Cardiac Insufficiency

Interventions

Type	Name	Description
OTHER	Implantable cardioverter-defibrillator	Collection of clinical, biological, hemodynamic and rhythmic data

Timeline

• Start date: 2015-09-01
• Primary completion: 2016-12-31
• Completion: 2016-12-31
• First posted: 2016-08-19
• Last updated: 2017-10-20

Locations

20 sites across 1 country: France